These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 10848883

  • 1. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease.
    Gebre-Medhin G, Husebye ES, Mallmin H, Helström L, Berne C, Karlsson FA, Kämpe O.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):775-80. PubMed ID: 10848883
    [Abstract] [Full Text] [Related]

  • 2. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [Abstract] [Full Text] [Related]

  • 3. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
    Libè R, Barbetta L, Dall'Asta C, Salvaggio F, Gala C, Beck-Peccoz P, Ambrosi B.
    J Endocrinol Invest; 2004 Sep; 27(8):736-41. PubMed ID: 15636426
    [Abstract] [Full Text] [Related]

  • 4. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial.
    Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, Huppert FA, Compston JE, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2008 Feb; 93(2):400-9. PubMed ID: 18000094
    [Abstract] [Full Text] [Related]

  • 5. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
    [Abstract] [Full Text] [Related]

  • 6. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W, Justl HG, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [Abstract] [Full Text] [Related]

  • 7. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
    Genazzani AD, Stomati M, Strucchi C, Puccetti S, Luisi S, Genazzani AR.
    Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
    [Abstract] [Full Text] [Related]

  • 8. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 9. Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells.
    Coles AJ, Thompson S, Cox AL, Curran S, Gurnell EM, Chatterjee VK.
    Eur J Immunol; 2005 Dec; 35(12):3694-703. PubMed ID: 16252254
    [Abstract] [Full Text] [Related]

  • 10. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F, Bélanger A, Cusan L, Candas B.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [Abstract] [Full Text] [Related]

  • 11. [Adrenopause and dehydroepiandrosterone: pharmacological therapy versus replacement therapy].
    Römmler A.
    Gynakol Geburtshilfliche Rundsch; 2003 Apr; 43(2):79-90. PubMed ID: 12649580
    [Abstract] [Full Text] [Related]

  • 12. Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization.
    Keane KN, Hinchliffe PM, Namdar N, Conceicao JL, Newsholme P, Yovich JL.
    Drug Des Devel Ther; 2015 Apr; 9():5569-78. PubMed ID: 26487801
    [Abstract] [Full Text] [Related]

  • 13. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ, Nolan JJ, Nelson JC, Yen SS.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
    [Abstract] [Full Text] [Related]

  • 14. Dehydroepiandrosterone replacement in addison's disease.
    Kim SS, Brody KH.
    Eur J Obstet Gynecol Reprod Biol; 2001 Jul; 97(1):96-7. PubMed ID: 11435018
    [Abstract] [Full Text] [Related]

  • 15. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women.
    Dhatariya K, Bigelow ML, Nair KS.
    Diabetes; 2005 Mar; 54(3):765-9. PubMed ID: 15734854
    [Abstract] [Full Text] [Related]

  • 16. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
    Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.
    Contraception; 2015 Feb; 91(2):127-33. PubMed ID: 25604900
    [Abstract] [Full Text] [Related]

  • 17. Hormonal changes in puberty III: Correlation of plasma dehydroepiandrosterone, testosterone, FSH, and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison's disease or hypogonadism or with premature or late adrenarche.
    Sizonenko PC, Paunier L.
    J Clin Endocrinol Metab; 1975 Nov; 41(5):894-904. PubMed ID: 127002
    [Abstract] [Full Text] [Related]

  • 18. Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism.
    Christiansen JJ, Gravholt CH, Fisker S, Møller N, Andersen M, Svenstrup B, Bennett P, Ivarsen P, Christiansen JS, Jørgensen JO.
    Eur J Endocrinol; 2005 Jan; 152(1):77-85. PubMed ID: 15762190
    [Abstract] [Full Text] [Related]

  • 19. Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender.
    Collomp K, Buisson C, Gravisse N, Belgherbi S, Labsy Z, Do MC, Gagey O, Dufay S, Vibarel-Rebot N, Audran M.
    Endocrine; 2018 Mar; 59(3):538-546. PubMed ID: 29322301
    [Abstract] [Full Text] [Related]

  • 20. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M, Gryczyńska M, Sowińska A, Sowiński J.
    Przegl Lek; 2011 Mar; 68(2):96-102. PubMed ID: 21751518
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.